Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J GROSSMAN

Showing results (341-350 of 385) with videos related to

Pageof 39
Sort By:
Lancet (London, England)|September 29, 1984
Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual menJ J Goedert, M G Sarngadharan, R J Biggar, et al.
Lancet (London, England)|October 22, 1988
Intensive therapy for children with acute lymphoblastic leukaemia and unfavourable presenting features. Early conclusions of study CCG-106 by the Childrens Cancer Study GroupP S Gaynon, P G Steinherz, W A Bleyer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 8, 2009
Comparative metabolism of 14C-labeled apixaban in mice, rats, rabbits, dogs, and humansDonglu Zhang, Kan He, Nirmala Raghavan, et al.
The Journal of Allergy and Clinical Immunology|January 23, 1998
Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthmaJ Corren, A G Harris, D Aaronson, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 28, 2005
Increased hepatobiliary clearance of unconjugated thyroxine determines DMP 904-induced alterations in thyroid hormone homeostasis in ratsHarvey Wong, Lois D Lehman-McKeeman, Mary F Grubb, et al.
Physiological Genomics|June 17, 2010
Multiplexed quantitative real-time PCR to detect 22q11.2 deletion in patients with congenital heart diseaseAoy Tomita-Mitchell, Donna K Mahnke, Joshua M Larson, et al.
Cancer|February 6, 1998
Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer GroupP G Steinherz, P S Gaynon, J C Breneman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 27, 2009
In vitro assessment of metabolic drug-drug interaction potential of apixaban through cytochrome P450 phenotyping, inhibition, and induction studiesLifei Wang, Donglu Zhang, Nirmala Raghavan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2017
Results of a Prospective Randomized, Open-Label, Noninferiority Study of Tbo-Filgrastim (Granix) versus Filgrastim (Neupogen) in Combination with Plerixafor for Autologous Stem Cell Mobilization in Patients with Multiple Myeloma and Non-Hodgkin LymphomaPavan Kumar Bhamidipati, Mark A Fiala, Brenda J Grossman, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 5, 2011
Preclinical pharmacokinetics and pharmacodynamics of apixaban, a potent and selective factor Xa inhibitorKan He, Joseph M Luettgen, Donglu Zhang, et al.
Pageof 39

Showing results (341-350 of 385) with videos related to

Sort By:
Pageof 39
Lancet (London, England)|September 29, 1984
Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual menJ J Goedert, M G Sarngadharan, R J Biggar, et al.
Lancet (London, England)|October 22, 1988
Intensive therapy for children with acute lymphoblastic leukaemia and unfavourable presenting features. Early conclusions of study CCG-106 by the Childrens Cancer Study GroupP S Gaynon, P G Steinherz, W A Bleyer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 8, 2009
Comparative metabolism of 14C-labeled apixaban in mice, rats, rabbits, dogs, and humansDonglu Zhang, Kan He, Nirmala Raghavan, et al.
The Journal of Allergy and Clinical Immunology|January 23, 1998
Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthmaJ Corren, A G Harris, D Aaronson, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 28, 2005
Increased hepatobiliary clearance of unconjugated thyroxine determines DMP 904-induced alterations in thyroid hormone homeostasis in ratsHarvey Wong, Lois D Lehman-McKeeman, Mary F Grubb, et al.
Physiological Genomics|June 17, 2010
Multiplexed quantitative real-time PCR to detect 22q11.2 deletion in patients with congenital heart diseaseAoy Tomita-Mitchell, Donna K Mahnke, Joshua M Larson, et al.
Cancer|February 6, 1998
Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer GroupP G Steinherz, P S Gaynon, J C Breneman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 27, 2009
In vitro assessment of metabolic drug-drug interaction potential of apixaban through cytochrome P450 phenotyping, inhibition, and induction studiesLifei Wang, Donglu Zhang, Nirmala Raghavan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2017
Results of a Prospective Randomized, Open-Label, Noninferiority Study of Tbo-Filgrastim (Granix) versus Filgrastim (Neupogen) in Combination with Plerixafor for Autologous Stem Cell Mobilization in Patients with Multiple Myeloma and Non-Hodgkin LymphomaPavan Kumar Bhamidipati, Mark A Fiala, Brenda J Grossman, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 5, 2011
Preclinical pharmacokinetics and pharmacodynamics of apixaban, a potent and selective factor Xa inhibitorKan He, Joseph M Luettgen, Donglu Zhang, et al.
Pageof 39